Literature DB >> 26994930

Pulmonary hypertension in thyroid diseases.

Pietro Scicchitano1, Ilaria Dentamaro2, Francesco Tunzi3, Gabriella Ricci2, Santa Carbonara2, Fiorella Devito2, Annapaola Zito2, Anna Ciampolillo4, Marco Matteo Ciccone5.   

Abstract

The influence of thyroid hormones on cardiovascular system is well established. Thyroid diseases can effectively enhance the alteration on cardiovascular system by influencing chronotropic and inotropic actions of the heart; altering the strength and the speed of contraction, the speed of relaxation, the duration of the potential of action, and the duration of the refractory period and atrio-ventricular conduction time; modulating circulation and peripheral vascular beds. One of the more intriguing insights in the connection between thyroid diseases and cardiovascular alterations is related to the evaluation of the influence of thyroid hormones on pulmonary vascular beds. Literature reported several studies regarding the association between both hypothyroidism and hyperthyroidism and the occurrence of increased vascular pulmonary arterial pressure. Nevertheless, the pathogenetic mechanisms able to explain such relationship are not fully understood. Many doubts still persist in the comprehension of the mechanisms of pulmonary hypertension in thyroid diseases. The aim of this review was to provide possible explanation about the possible interaction between pulmonary vascular beds and thyroid function in order to evaluate the possibility of novel perspectives in the general management of patients suffering from thyroid and cardiovascular diseases.

Entities:  

Keywords:  Endothelial function; Hyperthyroidism; Hypothyroidism; Pulmonary hypertension; Thyroid hormones

Mesh:

Year:  2016        PMID: 26994930     DOI: 10.1007/s12020-016-0923-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  79 in total

1.  Pediatric pulmonary arterial hypertension and hyperthyroidism: a potentially fatal combination.

Authors:  Christine M Trapp; Robert W Elder; Adrienne T Gerken; Aviva B Sopher; Shulamit Lerner; Gaya S Aranoff; Erika B Rosenzweig
Journal:  J Clin Endocrinol Metab       Date:  2012-05-23       Impact factor: 5.958

2.  An audit of amiodarone-induced thyrotoxicosis--do anti-thyroid drugs alone provide adequate treatment?

Authors:  Nadia Patel; Warrick J Inder; Clair Sullivan; Gerald Kaye
Journal:  Heart Lung Circ       Date:  2014-02-07       Impact factor: 2.975

Review 3.  Thyroid hormones and the heart.

Authors:  Hernando Vargas-Uricoechea; Carlos Hernán Sierra-Torres
Journal:  Horm Mol Biol Clin Investig       Date:  2014-04

4.  High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension.

Authors:  James W Chu; Peter N Kao; John L Faul; Ramona L Doyle
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

5.  Reversible pulmonary hypertension in neonatal Graves disease.

Authors:  D O'Donovan; C McMahon; C Costigan; P Oslizlok; D Duff
Journal:  Ir Med J       Date:  1997 Jun-Jul

6.  Pulmonary arterial hypertension in a patient with stage II sarcoidosis and Hashitoxicosis.

Authors:  S Ocak; F Feoli; J Fastrez; D Butenda; C Litvine; I M Colin; J-P d'Odémont
Journal:  Eur Respir Rev       Date:  2009-06

7.  Pulmonary hypertension responding to hyperthyroidism treatment.

Authors:  Mohamed Osama Hegazi; Amin El Sayed; Hussam El Ghoussein
Journal:  Respirology       Date:  2008-11       Impact factor: 6.424

Review 8.  Thyroid disease and the heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  Circulation       Date:  2007-10-09       Impact factor: 29.690

Review 9.  Mechanisms in endocrinology: Heart failure and thyroid dysfunction.

Authors:  Bernadette Biondi
Journal:  Eur J Endocrinol       Date:  2012-09-06       Impact factor: 6.664

10.  Autoimmunity and pulmonary hypertension in patients with Graves' disease.

Authors:  Tetsuro Sugiura; Shigeo Yamanaka; Hiroaki Takeuchi; Norihito Morimoto; Mikio Kamioka; Yoshihisa Matsumura
Journal:  Heart Vessels       Date:  2014-05-18       Impact factor: 2.037

View more
  14 in total

1.  Ischemia and No Obstructive Coronary Artery Disease and Pulmonary Hypertension in a 16-Year-Old Girl with Unquenched Hyperthyroidism of Graves' Disease.

Authors:  Meng-Luen Lee; Ming-Che Chang; Yu-Mei Wang
Journal:  Acta Cardiol Sin       Date:  2021-07       Impact factor: 2.672

Review 2.  Pulmonary hypertension associated with antiphospholipid antibody: Call for a screening tool?

Authors:  Rukma Parthvi; Rutuja R Sikachi; Abhinav Agrawal; Ajay Adial; Abhinav Vulisha; Sameer Khanijo; Arunabh Talwar
Journal:  Intractable Rare Dis Res       Date:  2017-08

Review 3.  Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension.

Authors:  Nils P Nickel; Ke Yuan; Peter Dorfmuller; Steeve Provencher; Yen-Chun Lai; Sebastien Bonnet; Eric D Austin; Carl D Koch; Alison Morris; Frédéric Perros; David Montani; Roham T Zamanian; Vinicio A de Jesus Perez
Journal:  Am J Respir Crit Care Med       Date:  2020-01-15       Impact factor: 21.405

4.  Impact of achieving euthyroidism on pulmonary artery systolic pressures in hyperthyroidism-associated pulmonary hypertension - a systematic review.

Authors:  Shireen R Chacko; Pradhum Ram; Tamaryn Fox; Naveen Sooknanan; Kevin Bryan Lo; Ritesh G Menezes; Savita Lasrado; Glenn Eiger; Anjali Vaidya
Journal:  Am J Cardiovasc Dis       Date:  2022-08-15

5.  The clinical characteristics and outcomes of patients with pulmonary hypertension in association with hyperthyroid state: A systematic review.

Authors:  Fateen Ata; Adeel Ahmad Khan; Zohaib Yousaf; Hassan Choudry; Areej Marwan Mohammed; Bilal Ahmed; Ahmed Muaaz Umer; Fareeha Khan; Dabia Hamad Sh Al Mohanadi; Emad Naem; Muhammad Zahid
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

Review 6.  Hematological disorders and pulmonary hypertension.

Authors:  Rajamma Mathew; Jing Huang; Joseph M Wu; John T Fallon; Michael H Gewitz
Journal:  World J Cardiol       Date:  2016-12-26

7.  Comparison of Linear and Non-linear Regression Analysis to Determine Pulmonary Pressure in Hyperthyroidism.

Authors:  Camelia C Scarneciu; Livia Sangeorzan; Horatiu Rus; Vlad D Scarneciu; Mihai S Varciu; Oana Andreescu; Ioan Scarneciu
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

8.  Echocardiographic evolution of pulmonary hypertension in female patients with hyperthyroidism.

Authors:  Cristina Tudoran; Mariana Tudoran; Mihaela Vlad; Melania Balas; Gheorghe Nicusor Pop; Florina Parv
Journal:  Anatol J Cardiol       Date:  2018-09       Impact factor: 1.596

9.  While your PAH patients skip by, don't forget to check their rhythm ….

Authors:  Ryan Davey
Journal:  Pulm Circ       Date:  2018 Apr-Jun       Impact factor: 3.017

10.  Severe Hypothyroidism due to the Loss of Therapeutic Efficacy of l-Thyroxine in a Patient with Esophageal Complication Associated with Systemic Sclerosis.

Authors:  Antonio Lobasso; Liliana Nappi; Letizia Barbieri; Carmela Peirce; Serena Ippolito; Debora Arpaia; Francesca Wanda Rossi; Amato de Paulis; Bernadette Biondi
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-20       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.